Ignite Creation Date:
2025-12-18 @ 9:08 AM
Ignite Modification Date:
2025-12-18 @ 9:08 AM
Study NCT ID:
NCT06295549
Status:
None
Last Update Posted:
2025-12-01 00:00:00
First Post:
2024-02-18 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-22
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-18 00:00:00
First Submit QC Date:
None
Study First Post Date:
2024-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24 00:00:00
Last Update Post Date:
2025-12-01 00:00:00
Last Update Post Date Type:
ESTIMATED